A popular group of drugs prescribed to slow bone loss may be putting some patients at an increased risk of hip fractures if taken for more than five years.
Two new studies show the bones of some post-menopausal women who take bisphosphonates (Actonel, Boniva, Fosamax) to ward off osteoporosis can stop rejuvenating and become brittle after long-term use. Researchers urge limiting the length of time people take the drugs.
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (5)
"That's the paradox," says Melvin Rosenwasser, chief of orthopedic trauma surgery at Columbia University Medical Center in New York. "These drugs are good drugs. They strengthen bone and protect you from fractures for a while. But in some people they can become deleterious after a period of time."
The Food and Drug Administration is reviewing the issue of long-term bisphosphonate use, says spokesperson Elaine Bobo.
Osteoporosis is a major health threat for the aging population. An estimated 10 million Americans have the disease and almost 34 million have low bone mass, putting them at risk for spine and hip fractures. Women are more likely to suffer from it than men.
- 1 vote
There is a safe, natural, whole food supplement out there for bisphosphonate users. It's called Osteodenx. It's clinically proven to regrow bone. The medical study was published in Osteoporosis Int'l. That's the same publication that Fosamax published their results in. I use it every day for my Osteoarthritis and disc degeneration. I no longer take Celebrex, or Advil. OsteoDenx has NO NEGATIVE side effects. Please check out bioreptecDOTcom for more information on OsteoDenx.
- 2 votes
Thanks, good info.
I have several seniors in my family I'll pass that on.
- 2 votes
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |



